App is temporarily unavailable
诊吾优
Published by:
Baoding Zhengwuyou Pharmaceutical Sales Co
Description
诊吾优医疗服务平台是为解决基层患者看病难等问题，采用互联网手段，通过打造互联网+医疗的服务，利用各个基层诊所医生资源，为患者提供向优质的医疗资源提供转诊服务的平台。同时通过分级诊疗机制，解决医疗资源分配不合理，通过信息分享提高基层诊所医生的诊疗水平
Screenshots
诊吾优 FAQ
-
Is 诊吾优 free?
Yes, 诊吾优 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 诊吾优 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 诊吾优 cost?
诊吾优 is free.
-
What is 诊吾优 revenue?
To get estimated revenue of 诊吾优 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Poland yet.
Ratings History
诊吾优 Reviews
诊吾优 Installs
Last 30 days
诊吾优 Revenue
Last 30 days诊吾优 Revenue and Downloads
Gain valuable insights into 诊吾优 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 2.1.2 (2 years ago )
- Released on
- Jan 11, 2021 (3 years ago )
- Also available in
- China , Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , Italy , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hungary , Indonesia , Ireland , Israel , United Arab Emirates
- Last Updated
- 11 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.